Cargando…

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives

Nucleos(t)ide analogues (NUCs) and interferon have been used for several decades to treat chronic hepatitis B; however, the therapeutic response remains unsatisfactory. Although NUC therapy exhibits potent on-treatment viral suppression, frequent off-therapy virological relapses suggest an indefinit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Tung-Hung, Liu, Chun-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593320/ https://www.ncbi.nlm.nih.gov/pubmed/28494575 http://dx.doi.org/10.5009/gnl16215

Ejemplares similares

Combination Therapy for Chronic Hepatitis B: Current Indications
por: Paul, Navin, et al.
Publicado: (2011)

Current Antiviral Therapy for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2004)

Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
por: Huang, Shang-Chin, et al.
Publicado: (2023)

Current Trend in Antiviral Therapy for Chronic Hepatitis B
por: Chien, Rong-Nan, et al.
Publicado: (2022)

Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B
por: Chao, Daniel C, et al.
Publicado: (2013)

Current landscape and perspective of oncolytic viruses and their combination therapies
por: Su, Yinghan, et al.
Publicado: (2022)

Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
por: Kim, Soon Sun, et al.
Publicado: (2011)

Current Therapy of Chronic Viral Hepatitis B, C and D
por: Schlaak, Jörg F.
Publicado: (2023)

Oxidative Stress in Chronic Hepatitis B—An Update
por: Popa, Gabriela Loredana, et al.
Publicado: (2022)

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2014)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients
por: Cheng, Huei-Ru, et al.
Publicado: (2013)

Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update
por: Lok, James, et al.
Publicado: (2021)

An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy
por: Cohen, Jared A., et al.
Publicado: (2020)

Current perspectives on combination therapy in the management of hypertension
por: Mallat, Samir G, et al.
Publicado: (2013)

Viral hepatitis update: Progress and perspectives
por: Pisano, María B, et al.
Publicado: (2021)

Lymphatic Senescence: Current Updates and Perspectives
por: Filelfi, Sebastian Lucio, et al.
Publicado: (2021)

Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus
por: Broquetas, Teresa, et al.
Publicado: (2022)

Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection
por: Chae, Hee Bok, et al.
Publicado: (2007)

Endoscopic therapy in chronic pancreatitis: current perspectives
por: Seicean, Andrada, et al.
Publicado: (2014)

Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus
por: Kumar, Manoj, et al.
Publicado: (2023)

Immunopathogenesis of Acute Flare of Chronic Hepatitis B: With Emphasis on the Role of Cytokines and Chemokines
por: Liu, Chieh, et al.
Publicado: (2022)

An Update on Photodynamic Therapy of Psoriasis—Current Strategies and Nanotechnology as a Future Perspective
por: Makuch, Sebastian, et al.
Publicado: (2022)

Interferon-Based Therapy for Chronic Hepatitis C: Current and Future Perspectives
por: Re, Valli De
Publicado: (2010)

An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease
por: Fabrizi, Fabrizio, et al.
Publicado: (2021)

Current update on combined hepatocellular-cholangiocarcinoma
por: Maximin, Suresh, et al.
Publicado: (2014)

New perspectives of biomarkers for the management of chronic hepatitis B
por: Lin, Chih-Lin, et al.
Publicado: (2016)

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
por: Su, Tung-Hung, et al.
Publicado: (2023)

Emerging hepatitis B virus infection in vaccinated populations: a rising concern?
por: Su, Tung-Hung, et al.
Publicado: (2012)

Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy
por: Ohsaki, Eriko, et al.
Publicado: (2021)

Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety
por: Lam, Yuk-Fai, et al.
Publicado: (2011)

Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis
por: Wu, Hsin-Yun, et al.
Publicado: (2023)

Current and novel modalities for management of chronic hepatitis B infection
por: Salama, Iman Ibrahim, et al.
Publicado: (2023)

Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update
por: Prasad, E. Maruthi, et al.
Publicado: (2021)

Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
por: Degasperi, Elisabetta, et al.
Publicado: (2014)

Hepatitis C Virus and Hepatitis B Virus Co-Infection
por: Shih, Yi-Fen, et al.
Publicado: (2020)

Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines
por: Chayama, Kazuaki, et al.
Publicado: (2012)

Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy
por: Škubník, Jan, et al.
Publicado: (2021)

Adult Medulloblastoma: Updates on Current Management and Future Perspectives
por: Franceschi, Enrico, et al.
Publicado: (2022)

Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bc10crb4fthqhlip6u9ntbir4k